• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - Moderna Inc.
Tag:

Moderna Inc.

News

Trump nominates Erica Schwartz as CDC director

by Rachel Morgan News Editor April 16, 2026
written by Rachel Morgan News Editor

President Donald Trump has nominated Erica Schwartz to serve as the director of the Centers for Disease Control and Prevention (CDC), ending a months-long search for a permanent leader of the agency.

Schwartz, who must be confirmed by the Senate, will enter the role as Health and Human Services Secretary Robert F. Kennedy Jr. Manages a series of controversial health policy changes. These changes include a significant overhaul of childhood vaccine recommendations.

A Background in Public Health and Military Service

Schwartz previously served as the deputy surgeon general during the first Trump administration, where she held a major role in the U.S. Response to the Covid-19 pandemic. She spent over 20 years in uniform, including service as a rear admiral and the chief medical officer of the Coast Guard.

According to official records, she holds a medical degree from Brown University and a law degree from the University of Maryland. She previously worked for 24 years in the Commissioned Corps of the US Public Health Service.

Did You Know? Under the federal Vacancies Act, an acting officer can only serve in place of a Senate-confirmed official for a maximum of 210 days.

Agency Turmoil and Leadership Shifts

The nomination follows a period of intense instability at the CDC. Dr. Jay Bhattacharya had been serving as the acting director, but his legal authority to do so expired last month under the Vacancies Act.

Agency Turmoil and Leadership Shifts
Secretary Kennedy Secretary Kennedy

The most recent confirmed director, Dr. Susan Monarez, served for less than a month last summer. In September, Monarez testified to Congress that she was fired after refusing demands from Secretary Kennedy to approve vaccine recommendations she believed lacked scientific support.

Beyond leadership disputes, the agency has struggled with plummeting morale and significant staff turnover. This environment was further strained by a gunman’s attack on the CDC’s Atlanta headquarters on August 8.

Expert Insight: The appointment of a nominee with a deep military and deputy surgeon general background may be a strategic move to instill discipline and stability in an agency currently reeling from internal upheaval and public trust deficits.

Controversies Over Vaccine Policy

The CDC is currently navigating a contentious shift in immunization policy. Last month, a judge blocked the efforts of a critical vaccine panel to reduce the number of recommended childhood shots from 17 to 11.

These policy shifts coincide with a decline in public confidence. A February poll from the health policy research group KFF indicates that trust in federal health agencies has plummeted across the political spectrum during Secretary Kennedy’s tenure.

Expanding the CDC Leadership Team

Alongside Schwartz, President Trump announced two other key appointments for the agency. Sean Slovenski has been chosen as the deputy CDC director and chief operating officer.

Trump nominates Erica Schwartz, former deputy surgeon general, to serve as CDC director

Jennifer Shuford will serve as the deputy CDC director and chief medical officer. Shuford previously led the Texas Department of State Health Services, where she credited vaccination and testing with ending a massive measles outbreak last year.

Potential Next Steps

The confirmation process in the Senate will likely be a critical next step in establishing permanent leadership. Depending on the outcome, the agency may spot a continued push for the policy overhauls championed by Secretary Kennedy.

It remains to be seen how Schwartz’s specific views on vaccines could align with or diverge from the current direction of the HHS Secretary.

Frequently Asked Questions

Who is Erica Schwartz?

Erica Schwartz is a former deputy surgeon general and a retired Coast Guard rear admiral and chief medical officer. She holds degrees in medicine from Brown University and law from the University of Maryland.

View this post on Instagram about Erica Schwartz, Schwartz
From Instagram — related to Erica Schwartz, Schwartz

Why was the previous CDC director fired?

Dr. Susan Monarez stated in congressional testimony that she was fired after refusing to approve vaccine recommendations demanded by Secretary Robert F. Kennedy Jr., which she believed lacked scientific support.

What is the current state of trust in the CDC?

According to a February poll by KFF, trust in federal health agencies has plummeted across the political spectrum during the tenure of HHS Secretary Robert F. Kennedy Jr.

How do you believe a permanent director will affect the current stability of federal health agencies?

April 16, 2026 0 comments
0 FacebookTwitterPinterestEmail
News

RFK Jr. casts doubts on vaccines, clashes with Democrats over Covid shot access

by Chief Editor September 4, 2025
written by Chief Editor

The Future of Public Health: Navigating Vaccine Policy and Trust in a Post-Pandemic World

The intersection of public health, political ideologies, and individual liberties has become increasingly complex, particularly concerning vaccine policies. Recent Senate testimony by Health and Human Services Secretary Robert F. Kennedy Jr. highlighted deep divisions and uncertainties surrounding the future of immunization programs in the United States. Let’s delve into the potential trends emerging from this evolving landscape.

The Shifting Sands of Vaccine Recommendations

One immediate trend is the increasing fragmentation of vaccine recommendations. The FDA’s recent decision to limit Covid shot approvals to specific age groups and risk categories signals a move away from universal recommendations. This shift necessitates a more nuanced approach at the state and local levels, creating a patchwork of policies that could lead to confusion and disparities in access.

For example, some states might adopt stricter guidelines based on local health data, while others may adhere more closely to broader federal recommendations. This decentralization places a greater burden on individuals to navigate complex information and make informed decisions, potentially exacerbating existing health inequities.

The Role of Advisory Committees

The composition and influence of advisory committees like the Advisory Committee on Immunization Practices (ACIP) will be pivotal. Kennedy’s decision to appoint members with varying viewpoints, including those critical of mRNA vaccines, suggests a move towards a more diverse, and potentially contentious, debate on vaccine safety and efficacy. While diverse perspectives are valuable, maintaining public trust requires transparency and a commitment to evidence-based decision-making.

Did you know? The ACIP plays a crucial role in determining which vaccines are recommended for different age groups and populations, influencing insurance coverage and public health guidelines nationwide.

mRNA Technology: Balancing Innovation and Public Perception

The future of mRNA vaccine technology hinges on addressing lingering public concerns. Despite overwhelming scientific evidence supporting the safety and effectiveness of mRNA vaccines, skepticism persists. This necessitates proactive communication strategies to debunk misinformation and highlight the benefits of this technology in preventing infectious diseases.

Consider the ongoing research into mRNA vaccines for influenza and other respiratory viruses. If these vaccines prove successful, they could revolutionize how we combat seasonal illnesses. However, realizing this potential requires building public trust and overcoming vaccine hesitancy.

Addressing Vaccine Hesitancy

Combating vaccine hesitancy requires a multi-faceted approach. Engaging with communities, addressing specific concerns, and promoting health literacy are essential. Furthermore, healthcare providers must be equipped with the resources and training to have informed conversations with patients about vaccines.

Pro Tip: Encourage open dialogue with your healthcare provider about any concerns you have regarding vaccines. They can provide personalized information and address your specific questions.

The Politicization of Public Health: A Growing Threat

The increasing politicization of public health poses a significant threat to the effectiveness of immunization programs. When scientific evidence is overshadowed by political ideologies, public trust erodes, and the ability to respond effectively to public health emergencies is compromised.

The recent leadership shakeup at the CDC, with accusations of political interference, underscores the need to safeguard the integrity of public health agencies. Maintaining scientific independence and transparency is crucial for ensuring that public health decisions are based on evidence, not political agendas.

Rebuilding Public Trust

Rebuilding public trust in public health institutions requires a concerted effort. This includes promoting scientific literacy, fostering open communication, and holding public officials accountable for disseminating accurate information. Furthermore, it requires depoliticizing public health issues and prioritizing evidence-based decision-making.

For example, public health campaigns should focus on clear, concise messaging that addresses common misconceptions about vaccines and highlights the benefits of immunization for individuals and communities. These campaigns should be developed in collaboration with community leaders and trusted healthcare providers to ensure they are culturally sensitive and effective.

Data Transparency and Accountability

Secretary Kennedy’s call for more data on Covid-related deaths and the effectiveness of vaccines highlights the importance of data transparency. While extensive data is available, ensuring its accessibility and understandability for the general public is crucial. Furthermore, rigorous analysis and independent verification of data are essential for maintaining public trust and informing policy decisions.

Reader Question: What steps can be taken to improve data transparency and accessibility in public health?

The CDC and other public health agencies should prioritize the publication of clear, concise data summaries that are easily accessible to the public. Furthermore, they should invest in data visualization tools and educational resources to help people understand complex statistical information.

FAQ: Navigating the Future of Vaccines

Will vaccine recommendations become more individualized?
Yes, expect a shift towards more tailored recommendations based on age, risk factors, and local health conditions.
How can I stay informed about vaccine policies in my area?
Consult your healthcare provider, local health department, and reputable sources like the CDC and WHO.
What can I do to combat vaccine misinformation?
Share credible information from trusted sources and engage in respectful conversations with those who have concerns.
Are mRNA vaccines safe?
Yes, extensive research and real-world data demonstrate the safety and effectiveness of mRNA vaccines.

The future of public health hinges on navigating complex challenges related to vaccine policy, public trust, and political interference. By prioritizing evidence-based decision-making, promoting transparency, and engaging in open communication, we can build a healthier and more resilient society.

Explore Further: Read more about vaccine safety and public health policy on our website.

Share your thoughts in the comments below. Subscribe to our newsletter for the latest updates on public health trends.

September 4, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

Trump administration cancels $766 million Moderna contract to fight pandemic flu | World News

by Chief Editor May 29, 2025
written by Chief Editor

Moderna’s Bird Flu Vaccine Funding Cut: What Does It Mean for Pandemic Preparedness?

The recent decision by the Trump administration to cancel $766 million in funding for Moderna’s bird flu vaccine development has raised eyebrows and ignited conversations about pandemic preparedness. This move, impacting a crucial initiative, prompts us to delve into the implications, examine the technology, and explore the evolving landscape of viral threats.

The Funding Freeze: A Closer Look

The withdrawn funds, originally slated for Moderna’s investigational vaccine against potential pandemic influenza viruses, particularly H5N1 bird flu, were to be distributed by the Biomedical Advanced Research and Development Authority (BARDA). This agency is a cornerstone in the U.S.’s strategy for responding to biological threats.

The impact is significant. The January award, for $590 million, was earmarked for a late-stage clinical trial to assess the vaccine’s effectiveness. This trial’s absence could delay the availability of a potentially life-saving vaccine.

mRNA Technology: A Game Changer with Skepticism

Moderna’s vaccine, designated mRNA-1018, harnesses the same mRNA technology that propelled the rapid development and rollout of COVID-19 vaccines. This technology offers the potential for swift adaptation to emerging viral threats, a critical advantage in a pandemic situation.

Did you know? The mRNA technology allows scientists to quickly create vaccines that teach our cells how to make a harmless piece of a virus, triggering an immune response. This is faster than traditional vaccine development methods.

However, the cancellation happened despite evidence showcasing the efficacy and safety of mRNA vaccines. These vaccines, like the COVID-19 vaccines, are widely considered safe and effective.

The Bird Flu Threat: Why We Need Vigilance

The H5N1 bird flu virus, while primarily affecting birds, has demonstrated the potential to spill over into other species, including mammals. The recent spillover into cattle in the U.S. highlights the evolving nature of this threat. Scientists are worried about mutations that could make the virus more transmissible to humans or more virulent.

Pro Tip: Stay informed about emerging viral threats by following reputable sources like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC).

The Future of Pandemic Preparedness: What’s Next?

The cancellation of funding could have far-reaching consequences, potentially slowing down vaccine development and leaving gaps in our defenses against future pandemics. The incident also raises concerns regarding the long-term strategic vision of government support for medical research. The availability of early-stage vaccines, developed through the use of mRNA technology, allows an important buffer to give society time to react to future viral threats.

It is important to keep in mind that, in 2024, the pandemic response field is still developing. Government funding for medical research, especially related to cutting-edge technology such as mRNA technology, helps drive innovation and prepare the public for future viral outbreaks.

Frequently Asked Questions (FAQ)

Q: Why was the funding canceled?

A: The official reason for the cancellation has not been fully clarified, but it occurred under the Trump administration.

Q: What is BARDA?

A: The Biomedical Advanced Research and Development Authority is a U.S. government agency focused on medical countermeasures for public health emergencies.

Q: How does mRNA technology work?

A: mRNA vaccines teach our cells to make a harmless piece of a virus, prompting the immune system to build defenses.

Q: Is bird flu a serious threat?

A: Bird flu poses a potential pandemic threat due to its ability to mutate and spread.

Q: What can I do to stay informed?

A: Follow credible sources like the WHO and CDC for updates on emerging health threats.

Q: What is the impact of funding cancellation?

A: It may slow down vaccine development and reduce readiness for future viral threats.

Q: What kind of mutations are scientists most concerned about?

A: Scientists are concerned about mutations that would make the virus more transmissible to humans, or more virulent.

Q: How is the vaccine being tested?

A: The vaccine is being tested in a Phase 1 trial with healthy adults.

Q: What do we know about the recent trials?

A: The interim results from the Phase 1 trials show a robust immune response, and a good safety profile.

Q: What is the difference between efficacy and effectiveness?

A: Efficacy is the measure of how well a vaccine works in a clinical trial, while effectiveness is how well it works in the real world.

May 29, 2025 0 comments
0 FacebookTwitterPinterestEmail
Health

EEUU Cancela Contrato con Moderna para Vacuna contra la Influenza

by Chief Editor May 29, 2025
written by Chief Editor

Moderna’s Vaccine Funding Cut: A Glimpse into Pandemic Preparedness and Future Challenges

The recent decision by the U.S. government to cancel $766 million in funding for Moderna’s influenza vaccine research has sent ripples through the scientific community. This move, focusing on a vaccine for potential pandemic strains like the H5N1 avian flu, highlights the complexities of funding, research, and the ever-present threat of emerging infectious diseases. Let’s dive into what this means for the future of vaccine development and pandemic preparedness.

Understanding the Funding Cut: What Happened and Why?

The Department of Health and Human Services (HHS) withdrew the funds allocated to Moderna for its mRNA-based influenza vaccine. This decision, made in a time of heightened awareness around potential pandemic threats, raises questions about priorities and strategic approaches to public health. While the specifics behind the funding cut remain somewhat unclear, several factors could be at play, including shifts in government priorities, budget constraints, or even concerns about the vaccine’s potential.

The funding, channeled through the Biomedical Advanced Research and Development Authority (BARDA), was initially meant to support the development and procurement of a vaccine targeting influenza viruses that could spark a pandemic. This includes the H5N1 avian flu, which has been spreading among livestock and, in some cases, infecting humans. The fact that Moderna had already demonstrated positive interim results in an early-stage trial adds another layer to the story.

The Role of mRNA Technology in Future Pandemics

Moderna’s vaccine leverages mRNA technology, the same platform that proved so effective in combating COVID-19. This technology’s speed and adaptability make it particularly promising for addressing rapidly evolving viruses.

Did you know? mRNA vaccines can be developed and manufactured much faster than traditional vaccines, offering a critical advantage in a pandemic scenario. The mRNA approach is extremely flexible, it can be quickly modified to target new viral strains as they emerge.

The cancellation of funding, despite these advancements, could potentially delay or hamper the development of crucial vaccines. It also underscores the importance of robust and diverse funding streams to ensure ongoing research and preparedness efforts.

The Ongoing Threat of Avian Flu and Pandemic Preparedness

The H5N1 avian flu poses a significant threat, with the potential to cause widespread human illness and, possibly, a global pandemic. Scientists are closely monitoring the virus’s mutations and its ability to spread among humans.

Pro tip: Stay informed about the latest public health advisories from organizations like the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) regarding emerging infectious diseases like avian flu. Early detection and swift responses are crucial in preventing and mitigating the impact of any future pandemic.

The cancellation has added uncertainty, yet Moderna’s ongoing studies and safety evaluations show promise for the future. This highlights the critical need for sustained research and development efforts in the field of vaccine production.

The importance of preparedness is now, perhaps more than ever, at the forefront of public health discussions. Exploring strategies to improve rapid-response frameworks, public health infrastructure, and international collaborations is essential to safeguard global health.

The Future of Vaccine Development: Key Trends and Innovations

Looking ahead, several trends will shape the future of vaccine development:

  • Rapid Response Technologies: mRNA technology and other rapid-response platforms will be crucial in developing and deploying vaccines swiftly during outbreaks.
  • Universal Flu Vaccines: Research into universal flu vaccines that offer protection against multiple strains will become increasingly important.
  • Personalized Vaccines: Advancements in genomics and immunology may lead to personalized vaccines tailored to individual immune responses.
  • Global Collaboration: International partnerships and information-sharing will play a crucial role in research, development, and distribution of vaccines.

These trends reflect a broader shift towards proactive rather than reactive approaches to disease prevention and pandemic management.

FAQ: Addressing Common Questions

  1. What is the H5N1 avian flu? H5N1 is a highly pathogenic strain of avian influenza (bird flu) that can infect humans.
  2. What is mRNA technology? Messenger RNA (mRNA) technology is used to instruct cells to produce a protein that triggers an immune response.
  3. Why is pandemic preparedness important? Early planning allows health institutions to manage outbreaks with reduced casualties, while also minimizing the disruptions caused by the pandemic.
  4. How can I stay informed? Follow reputable public health organizations like the CDC and WHO.

To learn more about pandemic preparedness and vaccine development, explore these resources:

  • CDC – Avian Flu
  • WHO – Influenza (Seasonal)

Share your thoughts! What measures do you think are most critical for global health preparedness in the face of potential pandemics? Let us know in the comments below!

May 29, 2025 0 comments
0 FacebookTwitterPinterestEmail

Recent Posts

  • Reactions of industry and leaders to Iran saying Hormuz is open

    April 18, 2026
  • Pope Leo Warns AI Threatens Truth and Fuels African Exploitation

    April 18, 2026
  • Some Singaporeans adjust spending amid Iran war, but hold on to comforts like air-con

    April 18, 2026
  • Zelenskyy Ready for Meeting With Putin in Turkey

    April 18, 2026
  • Fitnah Oplas Gagal, Rossa Lapor Bareskrim

    April 18, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

Hosted by Byohosting – Most Recommended Web Hosting – for complains, abuse, advertising contact: o f f i c e @byohosting.com


Back To Top
Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World